EntityWire

EntityWire / EIN 27-1041563

Employer with a benefit plan

ONCOCYTE CORPORATION

EIN 27-1041563. What DOL Form 5500 filings (EFAST2) and SEC EDGAR company filings say about this entity, with the source and date on every fact. Latest record 2026-08-10.

Employer with a benefit plan ยท SEC filer

ONCOCYTE CORPORATION

Also filed as Insight Molecular Diagnostics Inc.

15 CUSHING, IRVINE, CA 92618

EIN

27-1041563

SEC CIK

0001642380

SEC · 2026-08-10

Industry (SIC)

In Vitro & In Vivo Diagnostic Substances (2835)

SEC · 2026-08-10

State of incorporation

CA

SEC · 2026-08-10

Ticker

IMDX

SEC · 2026-08-10

Latest SEC filing

10-Q 2026-08-10

SEC · 2026-08-10

Benefit plan 1, 2024 filing

ONCOCYTE 401(K) PLAN

DOL · 2025-05-05

Participants (start of year)

85

DOL · 2025-05-05

Plan features

code 2T2E2G2J2K2F3D

DOL · 2025-05-05

Plan type

Single-employer plan

DOL · 2025-05-05

Business code (NAICS)

621510

DOL · 2025-05-05

Benefit plan 1, 2023 filing

ONCOCYTE 401(K) PLAN

DOL · 2024-04-23

Participants (start of year)

119

DOL · 2024-04-23

Plan features

code 2T2E2G2J2K2F3D

DOL · 2024-04-23

Plan type

Single-employer plan

DOL · 2024-04-23

From DOL Form 5500 filings (EFAST2) · SEC EDGAR company filings. Latest record 2026-08-10.

What this record is

Public federal filings that carry this EIN, shown as filed. Nothing here is scraped from the IRS and nothing is inferred.

What it is not

Registry status, formation date, and registered agent come from the California Secretary of State; search the California registry.

If something is wrong

A name, address, or classification here is what the source published. To correct the source, file with it; to have this page removed, see corrections and removal.

Look up another business

Free. Federal filings and state registries, stamped with their source and date.